BayBridge Capital Group, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1898297
LIVERMORE, CA
Position in REGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$503,820
+$178,539 QoQ
Shares Held
808
+91.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#802
of 1,322 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BayBridge Capital Group, LLC holds $503,820 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
808 | $503,820 |
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $503,820 | 808 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $325,281 | 421 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $324,957 | 421 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $233,904 | 416 | Shares | Sole | 2025-10-15 | |
| No filing history on record for this holder in this stock. | ||||||